Generic Estrace is used for treating conditions due to menopause (eg, hot flashes; vaginal itching, burning, or dryness), treating vulval or vaginal atrophy, and preventing osteoporosis (brittle bones). It is also used for estrogen replacement therapy after failure of the ovaries and to relieve the symptoms of breast cancer.
Generic Evista is used for treating and preventing osteoporosis (bone thinning) in women who are past menopause. It is also used to reduce the risk of invasive breast cancer in certain women who are past menopause.
Generic Premarin is used for treating certain symptoms of menopause (eg, hot flashes, vaginal dryness or itching). It is used to prevent osteoporosis (weak bones) after menopause in certain patients. It is also used in certain patients to treat low estrogen levels, prostate cancer or breast cancer.
High Prevalence of Bone Disease in Pulmonary Disease Patients - Newswise (press release)
High Prevalence of Bone Disease in Pulmonary Disease PatientsNewswise (press release)Newswise — ATS 2012, SAN FRANCISCO – There is a very high prevalence of osteopenia/osteoporosis among male patients with pulmonary disease, according to a new study from researchers in California.
Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And ... - MarketWatch (press release)
Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And .
`Manipulating` genes may boost lifespan - Zee News
Zee News`Manipulating` genes may boost lifespanZee NewsNow they expect that the laboratory breakthrough will one day lead to the creation of a pill that could extend life by decades and prevent or reverse diseases like cancer, osteoporosis and heart disease.
Healthy Advice: Osteoporosis is diagnosed in 2 percent of college aged women - Sulphur Southwest Daily News
Healthy Advice: Osteoporosis is diagnosed in 2 percent of college aged womenSulphur Southwest Daily NewsBy Staff reports Question: I'ma 29-year-old-woman just diagnosed with osteoporosis.
Osteoporosis - Pipeline Review, H1 2012 - New Market Research Report - SBWire (press release)
Osteoporosis - Pipeline Review, H1 2012 - New Market Research ReportSBWire (press release)Boston, MA -- (SBWIRE) -- 05/17/2012 -- Global Markets Direct's, 'Osteoporosis - Pipeline Review, H1 2012', provides an overview of the Osteoporosis therapeutic pipeline.
